DNA and protein methyltransferases inhibition by adenosine dialdehyde reduces the proliferation and migration of breast and lung cancer cells by downregulating autophagy
PLOS ONE · 2023
DOI: 10.1371/journal.pone.0288791 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Rose Ghemrawi und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Al Ain University, Abu Dhabi, United Arab Emirates. Hauptthemen laut MEDLINE: Lung Neoplasms, Breast Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Al Ain University.
Abstract (Originalsprache)
Protein and DNA methylation is involved in various biological functions such as signal transmission, DNA repair, and gene expression. Abnormal regulation of methyltransferases has been linked to multiple types of cancer, but its link to autophagy and carcinogenesis in breast and lung cancer is not fully understood. We utilized UALCAN, a web tool, to investigate breast and lung cancer database from The Cancer Genome Atlas. We found that 17 methyltransferases are upregulated in breast and/or lung cancer. We investigated the effect of methylation inhibition on two breast cancer cell lines (MDA-MB-231 and MCF-7) and two lung cancer cell lines (H292 and A549) by treating them with the indirect methyltransferase inhibitor adenosine dialdehyde (AdOx). We found that the migration ability of all cell lines was decreased, and the growth rate of MDA-MB-231, MCF-7 and H292 was also decreased after AdOx treatment. These results were correlated with an inhibition of the autophagy in MDA-MB-231, MCF-7 and H292 cell lines, since AdOx treatment induced a decreased expression of ATG7, a reduced ratio LC3-II/LC3-I and an increased p62 level. These findings suggest that inhibiting cells’ methylation ability could be a potential target for breast and lung cancer treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- College of Pharmacy, Al Ain University, Abu Dhabi, United Arab Emirates.
- AAU Health and Biomedical Research Center, Al Ain University, Abu Dhabi, United Arab Emirates.
- College of Pharmacy, Mansoura University, Mansoura, Egypt.
- Core Technology Platforms, New York University Abu Dhabi, Abu Dhabi, United Arab Emirates.
ORCID-Profile: Rose Ghemrawi
Förderung
- Al Ain University
Zitieren
APA
Ghemrawi, R., Al Qassem, A., Ramadan, A., Aldulaymi, R., Sammani, N., K Mousa, W., & Khair, M. (2023). DNA and protein methyltransferases inhibition by adenosine dialdehyde reduces the proliferation and migration of breast and lung cancer cells by downregulating autophagy. PLOS ONE. https://doi.org/10.1371/journal.pone.0288791
Vancouver
Ghemrawi R, Al Qassem A, Ramadan A, Aldulaymi R, Sammani N, K Mousa W, et al. DNA and protein methyltransferases inhibition by adenosine dialdehyde reduces the proliferation and migration of breast and lung cancer cells by downregulating autophagy. PLOS ONE. 2023. doi:10.1371/journal.pone.0288791
BibTeX
@article{Ghemrawi2023,
author = {Ghemrawi, Rose and Al Qassem, Aya and Ramadan, Azza and Aldulaymi, Raghad and Sammani, Nour and K Mousa, Walaa and Khair, Mostafa},
title = {DNA and protein methyltransferases inhibition by adenosine dialdehyde reduces the proliferation and migration of breast and lung cancer cells by downregulating autophagy},
journal = {PLOS ONE},
year = {2023},
doi = {10.1371/journal.pone.0288791}
}
EUVIMED